PARP7 INHIBITOR AND APPLICATION THEREOF - CHONGQING PHARSCIN PHARMACEUTICAL CO LTD

Title:

PARP7 INHIBITOR AND APPLICATION THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/020479

Kind Code:

A1

Abstract:

The present invention relates to a compound having a PARP7 inhibitory effect as shown in formula (I), and a pharmaceutically acceptable salt, a stereoisomer, a solvate, or a prodrug thereof, and use thereof and a preparation method therefor.

More Like This:

JP5452925	Pyrimidine amide compounds as PGDS inhibitors
JP2021507894	Substituted N-heterocyclyl- and N-heteroaryl-tetrahydropyrimidinone and salts thereof, as well as their use as herbicides
WO/2001/037820	IONIZABLE INDOLINONE DERIVATIVES AND THEIR USE AS PTK LIGANDS

Inventors:

WANG YUXUN (CN)
DUAN MAOSHENG (CN)
LIU XIAOHUI (CN)

Application Number:

PCT/CN2022/112746

Publication Date:

February 23, 2023

Filing Date:

August 16, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CHONGQING PHARSCIN PHARMACEUTICAL CO LTD (CN)

International Classes:

C07D401/14; A61K31/501; A61K31/506; A61P31/12; A61P35/00; A61P37/00; C07D403/14; C07D407/14; C07D409/14

Domestic Patent References:

WO2021087025A1	2021-05-06
WO2019055966A2	2019-03-21

Foreign References:

CN112424188A

2021-02-26

Attorney, Agent or Firm:

MERITS IP LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: CONTACT LENS AND MANUFACTURING METHOD THEREFOR

Next Patent: ANTI-COUNTERFEITING IMAGE ELEMENT AND ANTI-COUNTERFEITING PRODUCT